Cybin Inc (HELP) FinancialsHELPCybin Inc

In the context of the broader market, HELP competes directly with industry leaders such as SILO and OGEN. With a market capitalization of $807.31M, it holds a leading position in the sector. When comparing efficiency, HELP's gross margin of N/A stands against SILO's -14.77% and OGEN's N/A. Such benchmarking helps identify whether Helus Pharma Inc. is trading at a premium or discount relative to its financial performance.

The company has reported continuous net losses, with Q4 2026 net income at -46,995,000 CAD and a forward P/E ratio of 0, indicating no earnings expected in the near term.